Navigate biopharma services, inc. announces collaboration with bd (becton, dickinson and company) to advance capabilities for clinical phases of drug development

Carlsbad, calif. , sept. 7, 2023 /prnewswire/ -- navigate biopharma services, inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, announces a strategic collaboration with bd (becton, dickinson and company) (nyse:bdx), a leading global medical technology company, to explore opportunities to develop and commercialize flow cytometry-based companion diagnostics and tools for clinical decisions.
BDX Ratings Summary
BDX Quant Ranking